Leaderboard

En | De
No articles selected!     View Cart  
You are here: Dermatology » Psoriasis 03. March 2026
Search
medline.ch
Psoriasis
Advanced search
Dermatology
Acne
Alopecia
Dermatitis
Infectious Skin Diseases
Photosensitivity Disorder
Psoriasis
Skin Neoplasms
Skin Ulcer
Urticaria
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Zoom: Zoom In Zoom Out

   Page 1 of 1376  Previews Next
   
   Articles 1 - 20 / 27513  
   
Real-world outcomes of deucravacitinib in Chinese plaque psoriasis patients: a 24-week prospective study.
J Dermatolog Treat
Zhang Z, Tan X, Wu Z, Zhou J.
PMID: 41769731 [PubMed - in process]


Preferences of Chinese Dermatologists for Large Language Model Responses in Clinical Psoriasis Scenarios: A Nationwide Cross-Sectional Survey in China.
Health Care Sci
Yang J, Xu J, Song X, Li C, Chen L, Bi L, Jiang T, Zuo X, Cui Y.
PMID: 41767170 [PubMed]


From static pathology to dynamic immunity: immunological plasticity and histopathological remodeling in atopic dermatitis and psoriasis.
Front Immunol
Shen W, Yao Y, Ma YM, Xie XL, Tang SL, Wu Y, Zhong HJ, Li YM, Sun H.
PMID: 41766873 [PubMed - in process]


The dual potential of topical roflumilast: advancing psoriasis therapy and pioneering oral mucosal disease treatment.
Immunopharmacol Immunotoxicol
Sun J, Shi F, Li L.
PMID: 41766373 [PubMed - as supplied by publisher]


Microbial signatures in psoriatic arthritis distinguish disease phenotypes and newly diagnosed inflammatory bowel disease independent of faecal calprotectin.
Ann Rheum Dis
Boix-Amorós A, Bu K, Blank RB, Cantor A, Gutiérrez-Casbas A, Rodríguez-Lago I, Marin-Jimenez I, Sanz J, Masmitja JG, Trujillo E, Muñoz MC, Vivar MLG, Carrillo M, Hernández MVH, Calvet X, Salaet MA, Romero MI, García AB, Pérez S, Llorente JFG, Gonzalez-Lama Y, Argumánez CM, Plaza Z, Domínguez M, Cañete JD, Diaz-Gonzalez JF, Scher JU, Clemente JC.
PMID: 41763967 [PubMed - as supplied by publisher]


Composite and pragmatic measures in psoriatic arthritis: bridging trials and clinical feasibility.
Curr Opin Immunol
Kang JH, Coates LC.
PMID: 41763171 [PubMed - as supplied by publisher]


Joint Assessment Matters: Diagnostic and Therapeutic Benefits of Interdisciplinary Psoriasis Care.
Adv Ther
Dege T, Steffens O, Kiesel Ö, Bychkova I, Leichtfuss L, Schulze-Hagen T, Goebeler M, Schmalzing M, Leipe J, Olsavszky V, Strunz PP, Glatzel C, Schmieder A.
PMID: 41762372 [PubMed - as supplied by publisher]


Unravelling Fibromyalgia in Psoriatic Arthritis.
Rheumatol Ther
Findeisen KE, Guymer EK, Littlejohn GO.
PMID: 41758473 [PubMed - as supplied by publisher]


Biological Treatment of Psoriasis-Data So Far.
Pharmaceuticals (Basel)
Matwiejuk M, Mik, My, Chabowski A, Flisiak I.
PMID: 41754879 [PubMed]


The Relative Efficacy of Monotherapies for Palmoplantar Pustulosis and Palmoplantar Psoriasis: A Network Meta-Analysis Study of the Palmoplantar Spectrum.
Medicina (Kaunas)
Gupta AK, Bamimore MA, Wang T, Bhutani T, Piguet V, Talukder M.
PMID: 41752798 [PubMed - in process]


Increased Risk of Incident Uveitis Among Patients with Psoriasis: A Nationwide Population-Based Cohort Study.
Diagnostics (Basel)
Ehrenberg S, Elizur Y, Ben-Shabat N, David P, Sharif K, Bernstein YS, Abu Hilwe I, Cohen AD, Watad A, Amital H, Patt YS.
PMID: 41750775 [PubMed]


Impact of deucravacitinib on NLR and other inflammatory biomarkers of cardiovascular risk in psoriasis: post hoc analyses of phase 3 trials.
J Invest Dermatol
Luo Y, Bal AB, Balagula Y, Garshick M, Mehta NN.
PMID: 41747955 [PubMed - as supplied by publisher]


Ambient air pollution and psoriasis: a nationwide cross-sectional study of 149 744 Chinese patients in 31 provinces.
J Glob Health
Bi L, Wang Z, Yang J, Tian Z, Zhao H, Xu Z, Chen K, Zhuang Z, Huang X, Ouyang H, Sheng Y, Cui Y.
PMID: 41747084 [PubMed - in process]


Long-term osteoprotective effects of IL-17A blockade with secukinumab in psoriatic arthritis: data from the PSARTROS-II study.
RMD Open
Schuster L, Temiz A, Mutlu MY, Tascilar K, Bayat S, Corte G, Rech J, Hueber A, Liphardt AM, Kleyer A, Simon D, Roemer F, Schett G, Fagni F.
PMID: 41741168 [PubMed - in process]


Perceptions over biologics for psoriasis after 5 years of access in Brazil: a cross-sectional study.
J Dermatolog Treat
Leite LL, de Carvalho AVE, Smith C.
PMID: 41738157 [PubMed - indexed for MEDLINE]


The Psoriatic Disease Assessment Index (PSODAI) Score to Evaluate Systemic Involvement of Psoriasis.
Psoriasis (Auckl)
Liang Y, Deng B, Ntawuyamara E, Bachelez H, Wang F, Zhang H, Zhang Z, Li Z, Dang L, Wang Y, Zou X, Wang L, Duan D, Chen H, Zheng W, Huang H, Zhang M, Cai Q, Chen Y, Zhang Y, Lu Z, Ren Y, Huang J.
PMID: 41737997 [PubMed]


Obesity, skin disorders, and the microbiota: Unraveling a complex web.
J Microbiol
Woo YR, Kim HS.
PMID: 41736316 [PubMed - indexed for MEDLINE]


The challenges in managing Psoriatic Arthritis in resource poor settings.
Best Pract Res Clin Rheumatol
Nkeck JR, Adebajo AO, Maharaj AB.
PMID: 41735122 [PubMed - as supplied by publisher]


The Association Between the Aggregate Index of Systemic Inflammation (AISI) and Prevalence of Psoriasis: Cross Sectional NHANES Study 2003-2006 and 2009-2014.
Exp Dermatol
Zhao Y, Song J, Shen L, Chen B, Cai J, Yu Y, Yang L, Xi J, Qi L.
PMID: 41732102 [PubMed - indexed for MEDLINE]


On-label persistence in psoriasis after switching to guselkumab, tumor necrosis factor inhibitors, interleukin-17 inhibitors, or apremilast from other advanced therapies.
J Dermatolog Treat
Zhdanava M, Fitzgerald T, Boonmak P, Pilon D, Schwartzbein S, Libchaber B, Feldman SR.
PMID: 41732098 [PubMed - indexed for MEDLINE]


   
   Articles 1 - 20 / 27513    Page 1 of 1376  Previews Next

 
Rect Bottom
Adserver Footer
 

  Time frame  
   

Sky right 1